Tumor-Intrinsic Epigenetic Programs Associated with Nodal Burden and Metastatic Risk in ER+/HER2- Breast Cancer
Authors:
Preprint
- 26 June 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
De-escalation of axillary surgery in breast cancer (BC) reduces surgical morbidity but limits pathological assessment of nodal burden, a key determinant of prognosis and adjuvant therapy in estrogen receptor-positive (ER+)/HER2- BC. Tumor-intrinsic biomarkers that reflect the extent of lymph node disease may help bridge this gap. We performed genome-wide DNA methylation profiling of primary tumors from patients with ER+/HER2- BC stratified by pathological nodal stage (1-3 positive nodes, pN1; 4 or more positive nodes, >pN1). Findings were validated across multiple independent cohorts (TCGA-BRCA, SCAN-B, AURORA US), integrating molecular and clinical data. Forty-seven tumors passed EPIC quality control (pN1: n=29; >pN1: n=18). Tumors with >pN1 disease showed epigenetic reprogramming, including promoter hypermethylation and suppression of genes in pathways related to development and cell adhesion. Across datasets, five genes (TTC23, ARL10, RIC3, CXCL14, KCNH2) were consistently associated with nodal involvement and outcomes. Based on these genes, we developed the LION (Lymph-node Involvement Outcome Numerator) score, which distinguishes tumors with >pN1 disease and is associated with worse distant metastasis-free survival across cohorts. The LION score represents a biologically informed molecular metric associated with nodal involvement in ER+/HER2- BC. These findings provide insight into tumor-intrinsic epigenetic programs linked to dissemination.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- CADONOT: Comparing axillary dissection or not in breast cancer surgeryThe Breast, 2025
- VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cellsCell Reports, 2023
- Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironmentTranslational Oncology, 2023
- Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancerBreast Cancer Research and Treatment, 2022
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2017
- Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3Cell Reports, 2016
- Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapyBiomaterials, 2016
- The lymph node pre-metastatic nicheJournal of Molecular Medicine, 2015
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialThe Lancet Oncology, 2010